Prilosec: Effective Prescription-Strength Acid Reduction for GERD

Product dosage: 10mg
Package (num)Per capPriceBuy
90$0.59$53.22 (0%)🛒 Add to cart
180$0.52$106.44 $94.39 (11%)🛒 Add to cart
270$0.50$159.66 $135.56 (15%)🛒 Add to cart
360
$0.49 Best per cap
$212.88 $176.73 (17%)🛒 Add to cart
Product dosage: 20mg
Package (num)Per capPriceBuy
60$0.77$46.19 (0%)🛒 Add to cart
90$0.67$69.29 $60.25 (13%)🛒 Add to cart
120$0.62$92.38 $74.31 (20%)🛒 Add to cart
180$0.57$138.57 $102.42 (26%)🛒 Add to cart
270$0.54$207.86 $144.60 (30%)🛒 Add to cart
360
$0.52 Best per cap
$277.14 $185.77 (33%)🛒 Add to cart
Product dosage: 40mg
Package (num)Per capPriceBuy
30$1.84$55.23 (0%)🛒 Add to cart
60$1.31$110.46 $78.32 (29%)🛒 Add to cart
90$1.13$165.68 $101.42 (39%)🛒 Add to cart
120$1.03$220.91 $123.51 (44%)🛒 Add to cart
180$0.94$331.37 $168.70 (49%)🛒 Add to cart
270$0.88$497.05 $236.98 (52%)🛒 Add to cart
360
$0.85 Best per cap
$662.73 $305.26 (54%)🛒 Add to cart
Synonyms

Prilosec (omeprazole) is a proton pump inhibitor (PPI) indicated for the short-term treatment of gastroesophageal reflux disease (GERD), including erosive esophagitis, and other acid-related conditions. It works by directly inhibiting the proton pumps in the stomach lining, the final step of acid production, offering profound and sustained suppression of gastric acid secretion. This makes it a cornerstone therapy in gastroenterology for managing symptoms and promoting healing of damaged esophageal tissue. Available by prescription, it provides a targeted, medical-grade solution for those with persistent and severe acid-related disorders.

Features

  • Active ingredient: Omeprazole (20 mg delayed-release tablets)
  • Mechanism: Irreversible inhibition of H+/K+ ATPase (proton pump) in gastric parietal cells
  • Formulation: Delayed-release oral tablets designed to bypass stomach acid
  • Administration: Once-daily dosing, typically before a meal
  • Onset of action: Maximal acid suppression occurs within 2–4 hours after administration
  • Duration: Acid-suppressive effects persist for up to 72 hours due to irreversible enzyme binding
  • Prescription status: Available only with a valid prescription from a healthcare provider

Benefits

  • Provides significant and sustained relief from frequent heartburn and regurgitation associated with GERD
  • Promotes healing of erosive esophagitis and helps maintain remission
  • Reduces the risk of NSAID-induced gastric ulcers in at-risk patients
  • Allows for damaged esophageal tissue to recover by creating a low-acid environment
  • Improves overall quality of life by enabling normal eating and sleeping patterns free from acid disruption
  • Offers predictable, once-daily dosing for consistent therapeutic effect

Common use

Prilosec is commonly prescribed for the treatment of active duodenal ulcers, active benign gastric ulcers, erosive esophagitis, symptomatic GERD, and maintenance of healing of erosive esophagitis. It is also used in combination with antibiotics for the eradication of Helicobacter pylori in patients with duodenal ulcer disease. Additionally, it is indicated for the long-term treatment of pathological hypersecretory conditions, such as Zollinger-Ellison syndrome. It is not intended for immediate relief of heartburn; rather, it is used for conditions requiring sustained acid control.

Dosage and direction

The typical adult dosage for most indications is 20 mg taken orally once daily, before a meal—usually breakfast. For H. pylori eradication, it is used in combination with antibiotics (e.g., amoxicillin and clarithromycin) at a dosage of 20 mg twice daily. Tablets should be swallowed whole with water; they must not be crushed, chewed, or split, as this can compromise the delayed-release mechanism. Treatment duration varies by indication: 4–8 weeks for healing of erosive esophagitis, and up to 12 months for maintenance therapy in certain cases. Always follow the specific instructions provided by the prescribing physician.

Precautions

Use Prilosec with caution in patients with liver impairment, as omeprazole is metabolized hepatically. Long-term use (beyond one year) may be associated with an increased risk of fractures of the hip, wrist, and spine, particularly in older adults or those on high-dose, multiple daily PPI therapy. There is also a potential risk of hypomagnesemia with prolonged treatment; serum magnesium levels should be monitored in patients expected to be on long-term therapy or those taking concomitant medications such as digoxin or diuretics. Avoid use in patients with suspected gastric malignancy, as symptom relief may delay diagnosis.

Contraindications

Prilosec is contraindicated in patients with known hypersensitivity to omeprazole, substituted benzimidazoles, or any component of the formulation. It should not be used concomitantly with rilpivirine-containing products due to the potential for reduced antiviral efficacy. Use is also contraindicated with drugs that are dependent on CYP2C19 for clearance (e.g., clopidogrel) where omeprazole may inhibit their activation, though clinical relevance is subject to ongoing evaluation. Avoid in patients with a history of acute interstitial nephritis with prior PPI use.

Possible side effects

Common side effects include headache, abdominal pain, nausea, diarrhea, vomiting, and flatulence. Less frequently, dizziness, rash, and cough may occur. Serious adverse reactions, though rare, include acute interstitial nephritis, Clostridium difficile-associated diarrhea, cutaneous and systemic lupus erythematosus, cyanocobalamin (Vitamin B12) deficiency with long-term use, and hypomagnesemia. If any severe or persistent side effects occur, discontinue use and consult a healthcare provider immediately.

Drug interaction

Omeprazole is a substrate of CYP2C19 and CYP3A4 and may interact with drugs metabolized by these enzymes. It may reduce the absorption of drugs requiring acidic gastric pH for bioavailability, such as ketoconazole, iron salts, and mycophenolate mofetil. Concomitant use with clopidogrel may reduce the antiplatelet activity of the latter. Omeprazole may increase serum levels of diazepam, warfarin, and phenytoin. Caution is advised when co-administering with methotrexate due to potential increased methotrexate levels.

Missed dose

If a dose is missed, take it as soon as remembered, unless it is nearly time for the next scheduled dose. Do not double the dose to make up for a missed one. Resume the regular dosing schedule with the next dose. Consistent daily use is important for optimal acid suppression, so try to take Prilosec at the same time each day.

Overdose

There is limited experience with omeprazole overdose. Doses up to 2400 mg have been reported with no serious adverse effects. Symptoms of overdose may include confusion, drowsiness, blurred vision, tachycardia, nausea, sweating, flushing, headache, and dry mouth. Management is supportive and symptomatic; there is no specific antidote. Hemodialysis is not effective in removing omeprazole due to high protein binding. In case of suspected overdose, seek immediate medical attention.

Storage

Store Prilosec tablets at room temperature, between 20°C to 25°C (68°F to 77°F), in a dry place. Keep in the original container with the lid tightly closed to protect from moisture and light. Do not store in the bathroom or near sinks. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging.

Disclaimer

This information is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Do not disregard professional medical advice or delay in seeking it because of something you have read here.

Reviews

Clinical studies and post-marketing surveillance have demonstrated Prilosec’s efficacy in healing erosive esophagitis in over 80% of patients after 8 weeks of therapy. It is widely regarded among gastroenterologists as a first-line treatment for moderate to severe GERD. Patient-reported outcomes frequently cite significant improvement in nighttime heartburn and regurgitation symptoms, though individual responses may vary. Long-term users should be periodically reevaluated for continued need and monitored for potential nutrient deficiencies or bone health impacts.